Back to DE D. E. Shaw & Co., Inc.
HALOShowing 8 of 31 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in HALOZYME THERAPEUTICS INC
D. E. Shaw & Co., Inc. holds 2M shares of HALO (HALOZYME THERAPEUTICS INC), worth $157M as of 2026-Q2. The position was increased (+7.4% shares). HALO represents 0.1% of D. E. Shaw & Co., Inc.'s portfolio.
Current Value
$157M
Current Shares
2M
Total Value Change
+$139.5M
Total Shares Change
+1.7M
Quarter-by-Quarter History
Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.